A Phase III Study of JSKN016 Versus Treatment of Physician's Choice in Patients With Triple-Negative Breast Cancer Who Have Failed Standard of Care
- Status
- RECRUITING
- Phase
- PHASE3
Clinical Trials Related to Triple Negative Breast Cancer
Related studies linked through entity extraction aliases.
Gemcitabine vs Paclitaxel in Caribbean Women of African Ancestry With Metastatic Triple-Negative Breast Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
A Study of IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors Types
- Status
- RECRUITING
- Phase
- PHASE1
Early Detection of Metastatic Recurrence Among Patients With Stage II or III Triple Negative Breast Cancer Using Liquid Biopsy and Imaging
- Status
- NOT_YET_RECRUITING
- Phase
- NA
A Study of ITC-6146RO in Patients With Advanced or Metastatic Cancer Who Have Failed Standard Therapy
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1
Omission of Surgery for Triple-negative Breast Cancer in Complete Response After Neoadjuvant Chemo-immunotherapy
- Status
- NOT_YET_RECRUITING
- Phase
- NA
Systemic Anti-Cancer Therapy Dose Modifications for Individuals With Duffy Null Phenotype
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1
Evolutionary Clinical Trial for Novel Biomarker-Driven Therapies
- Status
- RECRUITING
- Phase
- PHASE2
ctDNA Positive Patients Diagnosed With cT1bN0 and cT1cN0 TNBC
- Status
- RECRUITING
- Phase
- N/A
A Study to Learn About the Study Medicine Called PF-08032562 in People With Advanced or Metastatic Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1
Cancer Immunotherapeutic (PCI) Strategy in Triple Negative Breast Cancer Patients
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1
GCAR1, a Chimeric Antigen Receptor (CAR) T-CELL Therapy for Relapsed/Refractory GPNMB-Expressing Solid Tumours
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1
Neoadjuvant Serplulimab Plus Weekly Paclitaxel and Carboplatin in TNBC (Neo-SERPENT)
- Status
- RECRUITING
- Phase
- PHASE2
A Trial of LBL-024 Monotherapy or Combination Drug in Patients With Triple Negative Breast Cancer
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Phase I Study of [177Lu]Lu-DFC413 in Patients With Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1
Neoadjuvant Complete Response Customized Treatment Approach for Definitive Management of Breast Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1/PHASE2
Sacituzumab Tirumotecan Plus Anlotinib for Metastatic Triple Negative Breast Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1/PHASE2
Phase II Trial Evaluating the Safety and Efficacy of the Combination of Zimberelimab, Domvanalimab and Sacituzumab Govitecan as 1L Therapy for PD-L1 Positive Advanced TNBC
- Status
- WITHDRAWN
- Phase
- PHASE2
A Study to Investigate Safety of AZD6750 in Adult Participants With Select Advanced or Metastatic Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
BCD-236 in Combination With Chemotherapy in Patients With Relapsed and/or Metastatic Triple Negative Breast Cancer
- Status
- RECRUITING
- Phase
- PHASE2